Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Juliette Kempf"'
Autor:
Johann Foloppe, Juliette Kempf, Nicolas Futin, Jacqueline Kintz, Pascale Cordier, Christelle Pichon, Annie Findeli, Fabien Vorburger, Eric Quemeneur, Philippe Erbs
Publikováno v:
Molecular Therapy: Oncolytics, Vol 14, Iss , Pp 1-14 (2019)
Oncolytic vaccinia viruses are currently in clinical development. However, the safety and the tumor selectivity of these oncolytic viruses must be improved. We previously constructed a first-generation oncolytic vaccinia virus by expressing the suici
Externí odkaz:
https://doaj.org/article/35a655137d434081af3a44ab9dfcb826
Autor:
Philippe Erbs, Annie Findeli, Johann Foloppe, Juliette Kempf, Isabelle Farine, Baptiste Moreau, Julie Hortelano, Christelle Pichon, Jules Deforges, Eric Quemeneur
Publikováno v:
Cancer Research. 83:6796-6796
Oncolytic virus (OV) therapy has emerged as a promising approach for cancer treatment with the potential to be less toxic and more efficient than classic cancer therapies. Various types of OVs in clinical development, including Vaccinia virus (VACV)-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::486168b7be0dae9647bd796f09e698bc
https://doi.org/10.1158/1538-7445.am2023-6796
https://doi.org/10.1158/1538-7445.am2023-6796
Autor:
Jacqueline Kintz, Nicolas Futin, Juliette Kempf, Christelle Pichon, Johann Foloppe, Annie Findeli, Philippe Erbs, Pascale Cordier, Fabien Vorburger, Eric Quemeneur
Publikováno v:
Molecular Therapy: Oncolytics, Vol 14, Iss, Pp 1-14 (2019)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Oncolytic vaccinia viruses are currently in clinical development. However, the safety and the tumor selectivity of these oncolytic viruses must be improved. We previously constructed a first-generation oncolytic vaccinia virus by expressing the suici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a893073f7ee89e8b640d248e09f14bca
https://doi.org/10.1016/j.omto.2019.03.005
https://doi.org/10.1016/j.omto.2019.03.005
Autor:
Johann Foloppe, Nathalie Silvestre, Véronique Koerper, Renée Brandely, Baptiste Moreau, Isabelle Farine, Christelle Machon, Christelle Pichon, Julie Hortelano, Eric Quéméneur, Juliette Kempf, Philippe Erbs, Michèle Klein, Jérôme Guitton, Sandrine Cochin, Annie Findeli
Publikováno v:
Cancer Research. 80:4576-4576
The recombinant Vaccinia virus Copenhagen strain deleted in Thymidine Kinase and Ribonucleotide Reductase (VVCOPTK−RR−) is a potent and versatile oncolytic platform that has demonstrated strong activity in various preclinical models. The deletion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52da0cd1e5096baaf18df1b5e086adb7
https://doi.org/10.1158/1538-7445.am2020-4576
https://doi.org/10.1158/1538-7445.am2020-4576
Autor:
Christelle Remy-Ziller, Eric Quemeneur, Chantal Hoffmann, Patricia Kleinpeter, Murielle Gantzer, Juliette Kempf, Jean-Baptiste Marchand, Laetitia Fend, Nathalie Silvestre, Dominique Villeval, H. Schultz, Eline Winter, Christine Thioudellet, Doris Schmitt, Y. Schlesinger, Johann Foloppe, Philippe Erbs, Catherine Brua, Virginie Nourtier, Michel Geist, Julie Hortelano
Publikováno v:
Journal of Virology
The vaccinia virus harbors in its genome several genes dedicated to the inhibition of the host immune response. Among them, M2L was reported to inhibit the intracellular NF-κB pathway. We report here several new putative immunosuppressive activities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5534c493f1080a5522f56ffab1b433
http://europepmc.org/articles/PMC6532080
http://europepmc.org/articles/PMC6532080
Autor:
Delphine Antoine, Pascale Cordier, Johann Foloppe, Marine Ricordel, Benoît Grellier, Juliette Kempf, Eric Quemeneur, Annie Findeli, Aude Gerbaud, Philippe Erbs, Monika Lusky
Publikováno v:
Cancers, Vol 10, Iss 7, p 231 (2018)
Cancers
Volume 10
Issue 7
Cancers
Volume 10
Issue 7
Oncolytic virus (OV) therapy has emerged as a promising approach for cancer treatment with the potential to be less toxic and more efficient than classic cancer therapies. Various types of OVs in clinical development, including Vaccinia virus (VACV)-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce79b8422e7684370186c8badf3e624
http://www.mdpi.com/2072-6694/10/7/231
http://www.mdpi.com/2072-6694/10/7/231
Autor:
Juliette Kempf
Publikováno v:
Chimères. :226
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::322192dad16b1569dd03c3215ab8b253
https://doi.org/10.3917/chime.095.0226
https://doi.org/10.3917/chime.095.0226
Autor:
Nathalie Accart, Sandrine Cochin, Laetitia Fend, Xavier Préville, Luc Barraud, Juliette Kempf, Sylvie Fournel, Philippe Erbs, Christelle Remy-Ziller, Johann Foloppe
Publikováno v:
Oncoimmunology
Oncolytic virotherapy is an emergent promising therapeutic approach for the treatment of cancer. We have constructed a vaccinia virus (WR strain) deleted for thymidine kinase (TK) and ribonucleotide reductase (RR) genes that expressed the fusion suic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672c41f5544286048c27877523af7b0d
http://europepmc.org/articles/PMC4801465
http://europepmc.org/articles/PMC4801465
Autor:
Charlotte Schmitt, Jean-Yves Delattre, Ludovic Nguyen Them, Philippe Erbs, Juliette Kempf, Hervé Chneiweiss, Ahmed Idbaih, Michel Homerin, Johann Foloppe
Publikováno v:
Journal of Clinical Oncology. 35:e13510-e13510
e13510 Background: Glioblastoma (GBM) is an incurable disease challenging innovations for significant therapeutic progress. TG6002 is a vaccinia virus that replicates mainly in tumor cells after deletion of genes coding for thymidine kinase and ribon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95a54a3d45cf788439fbe89c29253478
https://doi.org/10.1200/jco.2017.35.15_suppl.e13510
https://doi.org/10.1200/jco.2017.35.15_suppl.e13510
Autor:
Kenneth Lundstrom, Nicolas André, Cécile Prual, Christoph Reinhart, Juliette Kempf, Ghérici Hassaine, Franc Pattus, Nhouzha Hassaine, Nadja Cherouati, Renaud Wagner
Publikováno v:
Protein Expression and Purification
Protein Expression and Purification, Elsevier, 2006, 45 (2), pp.343-351. ⟨10.1016/j.pep.2005.06.007⟩
Protein Expression and Purification, Elsevier, 2006, 45 (2), pp.343-351. ⟨10.1016/j.pep.2005.06.007⟩
Semliki Forest virus vectors were applied for the evaluation of 101 G protein-coupled receptors in three mammalian cell lines. Western blotting demonstrated that 95 of the 101 tested GPCRs showed positive signals. A large number of the GPCRs were exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b83a4c5365b9d5f9b3ce6d03a6464b66
https://linkinghub.elsevier.com/retrieve/pii/S1046592805001932
https://linkinghub.elsevier.com/retrieve/pii/S1046592805001932
